Skip to main content

Table 1 Antibodies used in this study

From: The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis

  Host species Dilution Supplier Application in this study
Primary antibodies
 Anti-β-Tubulin class III Rabbit 1:1000 Abcam, Melbourne, VIC, Australia Cross sections
 Anti-CD45 (clone IH-1) Mouse 1:200 Abcam, Melbourne, VIC, Australia Cross sections
 Anti-choline acetyltransferase (ChAT) Goat 1:500 Merck Millipore, Bayswater, Australia LMMP preparations
 Anti-Hu (clone 15A7.1) Mouse 1:500 Merck Millipore, Bayswater, VIC, Australia LMMP preparations
 Anti-neuronal nitric oxide synthase (nNOS) Goat 1:500 Novus Biologicals, Littleton, CO, USA LMMP preparations
 Anti-human leucocyte antigen (HLA)-A,B,C (conjugated to fluorescein isothiocyanate (FITC)) Human 1:50 BioLegend, San Diego, CA, USA Cross sections
Secondary antibodies
 Alexa Fluor 594 Donkey anti-mouse 1:200 Jackson Immunoresearch Labs, West Grove, PA, USA LMMP preparations
 Alexa Fluor 594 Donkey anti-rabbit 1:200 Jackson Immunoresearch Labs, West Grove, PA, USA Cross sections
 FITC 488 Donkey anti-goat 1:200 Jackson Immunoresearch Labs, West Grove, PA, USA LMMP preparations
 FITC 488 Donkey anti-mouse 1:200 Jackson Immunoresearch Labs, West Grove, PA, USA Cross sections
  1. LMMP longitudinal muscle-myenteric plexus